| 000 | 01540 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250514184755.0 | ||
| 264 | 0 | _c20040803 | |
| 008 | 200408s 0 0 eng d | ||
| 022 | _a0269-9370 | ||
| 024 | 7 |
_a10.1097/00002030-200404300-00022 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMorsica, Giulia | |
| 245 | 0 | 0 |
_aComparison of IFN-alpha 2b with or without ribavirin for treatment of chronic hepatitis C in HIV-positive patients infected with hepatitis C virus genotype 3a. _h[electronic resource] |
| 260 |
_bAIDS (London, England) _cApr 2004 |
||
| 300 |
_a1080-2 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; Letter; Comment | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHIV Infections _xcomplications |
| 650 | 0 | 4 |
_aHepacivirus _xclassification |
| 650 | 0 | 4 |
_aHepatitis C, Chronic _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInterferon alpha-2 |
| 650 | 0 | 4 |
_aInterferon-alpha _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRecombinant Proteins |
| 650 | 0 | 4 |
_aRibavirin _xtherapeutic use |
| 700 | 1 | _aBruno, Raffaele | |
| 700 | 1 | _aBagaglio, Sabrina | |
| 700 | 1 | _aDe Mitri, Maria Stella | |
| 700 | 1 | _aAndreone, Pietro | |
| 700 | 1 | _aLazzarin, Adriano | |
| 773 | 0 |
_tAIDS (London, England) _gvol. 18 _gno. 7 _gp. 1080-2 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00002030-200404300-00022 _zAvailable from publisher's website |
| 999 |
_c14809360 _d14809360 |
||